Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
HSBC is bullish on Biopharma stocks By Investing.com
© Reuters. HSBC is bullish on Biopharma stocks HSBC analysts initiated research coverage of Biopharma stocks with a predominantly positive view. The analysts argue that
Biopharma Y-mAbs Stokes Investor Excitement With Latest Results and Restructuring Progress
Commercial-stage biopharma stock Y-mAbs Therapeutics Inc (US:YMAB), reported fourth quarter and full year 2022 results on Thursday post market, sending shares up 12.5% in extended